In cases of bladder cancer, omission of muscle in specimen or its mention in pathology report is linked to increased mortality.
Examination of the DNA of a thyroid cancer survivor has revealed details about resistance to the drug everolimus, according to researchers.
A new technique to treat retinoblastoma may help prevent eye loss, blindness, or death in children with advanced forms of the disease.
Clinical trials could benefit from a greater number of participants with a dedicated cooperative network to support rural community cancer centers.
Lung cancer can remain dormant in the body for many years before emerging in an aggressive form, according to new research.
A new strategy developed by an interdisciplinary team of researchers aims to reduce the side effects connected to use of tyrosine kinase inhibitors (TKIs).
Coupling immunotherapy to radiotherapy treatment could help prevent cancers from becoming resistant to treatment, according to a new study.
A recent review has found insufficient consistent data exist to recommend a change in use of levothyroxine as the only drug needed to treat hypothyroidism.
Is sequencing important when administering chemotherapy on the same day?
In a study of more than 1.1 million cancer patients who had surgery, almost 5 percent died within one month of their operation. Lack of access to quality care a major factor in these deaths, researchers say.
Treatnent with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to phase II trial data.
After failure of platinum-based chemotherapy, the tyrosine kinase inhibitor (TKI) afatinib significantly improved progression-free survival in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Guidelines for managing chemotherapy-induced nausea and vomiting direct management toward risk assessment and prophylactic antiemetics.
Human epidermal growth factor receptor 2 (HER2) mutations may offer an important treatment target in a subset of patients with non-small cell lung cancer.
For younger patients with an acute lymphoblastic leukemia (ALL) subtype, modifying treatment based on chemotherapy response can make a vital difference.
Successful colonoscopy is closely dependent on good bowel preparation, and poor bowel prep often leads to missed precancerous lesions.
Smokers with cancer using e-cigarettes (in addition to traditional cigarettes) were found to be more nicotine dependent and equally or less likely to have quit smoking traditional cigarettes than nonusers.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieved superior results over vemurafenib plus placebo for BRAF-mutation positive melanoma.
The use of trastuzumab (Herceptin) as the standard-of-care treatment for HER2-positive breast cancer has been supported by the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) study.
Researchers have successfully tested a new tool that will help surgeons better distinguish cancerous breast tissue from normal tissue, which should lower the mount of repeat procedures needed.
A targeted combination drug therapy has shown efficacy for metastatic melanoma, showing reduction in both mortality and disease progression.
A newly developed antifungal has proved as effective against invasive mold disease in cancer patients as the standardly used drug, voriconazole, with fewer side effects.
A shoulder surgical aid, known as the Spider Limb Positioner, was adapted successfully to conduct a left hip disarticulation on a patient with melanoma.
An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.
An active controversy among oncologists concerns watchful waiting versus more active treatment for prostate cancer.
Radiation therapy with concurrent paclitaxel chemotherapy after surgery can be effective to treat patients with high-risk endometrial cancer, according to new research.
A medical center in New Jersey makes the most of a rare opportunity to rebuild from the ground up. Its innovative patient rooms follow evidence-based design, a new concept in health care architecture.
A PARP inhibitor in oral tablet form, given in combination with chemotherapy, was deemed safe for heavily pretreated patients with ovarian cancer.
Malignant melanoma was differentiated from benign skin lesions with high accuracy in a pivotal clinical utility study of the Myriad myPath Melanoma test.
Scientists have developed a tool to distinguish each breast cancer subtype, research that could improve treatments and targeting of treatments for the disease.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|